Award
NIH Reporter #5R01HD104599-05
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)
Recipient
Columbia University Health Sciences
Award Amount
$2,452,419.00
Ceiling
$2,452,419.00
Awarded
July 15, 2024
Identifier
5R01HD104599-05
The project investigates how dolutegravir use during pregnancy affects maternal and child metabolic health, including weight gain, adiposity, and metabolic outcomes.
Description
Study of the impact of dolutegravir use during pregnancy on the metabolic health of women living with HIV and their children in South Africa.